Novan, Inc.
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
(0.0% 1d) (0.0% 1m) (-93.0% 1y) (0.0% 2d) (0.0% 3d) (-24.8% 7d) (318.21% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 2,636,246
http://www.novan.com
Sec Filling | Patents | 42 employees
(US) Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.
dermatological antiviral
add to watch list Paper trade email alert is off
Press-releases
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
Published: 2024-04-03 (Crawled : 14:30) - biospace.com/
LGND | News | $78.93 -1.24% -1.25% 180K
|
Health Technology
|
| O: -0.83%
H: 3.14%
C: 2.93%
pharmaceuticals commercialization therapeutics
Delisting of Securities of Nymox Pharmaceutical Corporation; Aridis Pharmaceuticals Inc.; Novan, Inc.; ViewRay, Inc.; 9 Meters Biopharma, Inc.; Nabriva Therapeutics plc; UTA Acquisition Corporation; AppHarvest, Inc.; Yellow Corporation; Proterra Inc.; Amyris, Inc.; Chain Bridge I; LatAmGrowth SPAC; and SpringBig Holdings, Inc. from The Nasdaq Stock Market
Published: 2023-09-07 (Crawled : 20:00) - globenewswire.com
AMRSQ | $0.004 -95.0% 31K
|
Manufacturing
|
| O: -10.0%
H: 16.05%
C: 8.64%
VRAYQ | $0.0001 0.0% 600
|
Manufacturing
|
| O: 6.84%
H: 13.6%
C: -4.0%
NDAQ | News | $60.01 -0.03% -0.03% 2.8M
|
Finance
|
| O: 0.0%
H: 0.19%
C: -0.45%
ARDS | $0.0705 2.82% 20K
|
Health Technology
|
| O: 0.0%
H: 13.45%
C: -12.07%
nasdaq acquisition pharmaceuticals therapeutics proterra market
Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
Published: 2023-07-17 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -63.13%
H: 2.09%
C: -20.11%
LGND | News | $78.93 -1.24% -1.25% 180K
|
Health Technology
|
| O: 0.94%
H: 1.74%
C: 0.39%
sb206 agreement
Ligand Offers $15 Million to Acquire Assets of Novan, Inc.
Published: 2023-07-17 (Crawled : 14:20) - biospace.com/
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -63.13%
H: 2.09%
C: -20.11%
LGND | News | $78.93 -1.24% -1.25% 180K
|
Health Technology
|
| O: 0.94%
H: 1.74%
C: 0.39%
acquire
Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Published: 2023-06-05 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 2.65%
H: 4.31%
C: -0.86%
update meeting
Novan Focuses Strategic Direction and Announces Restructuring
Published: 2023-05-31 (Crawled : 20:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -8.82%
H: 0.0%
C: -9.68%
Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-15 (Crawled : 11:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -6.25%
H: 1.58%
C: -3.33%
update financial results
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
Published: 2023-05-08 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -0.88%
H: 4.42%
C: -1.77%
report financial results
Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹
Published: 2023-04-27 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -1.61%
H: 4.1%
C: 0.82%
rapid psoriasis publication
Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD
Published: 2023-04-20 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -2.24%
H: 3.05%
C: 1.53%
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10